Lymph node involvement in T1 non-small-cell lung cancer: Could glucose uptake and maximal diameter be predictive criteria?

European Journal of Cardio-thoracic Surgery

Volumn 39, Issue 4, 2011, Pages

  Casiraghi, Monica ^a   Travaini, Laura L ^a   Maisonneuve, Patrick ^a   Tessitore, Adele ^a   Brambilla, Daniela ^a   Agoglia, Bernardo G ^a   Guarize, Juliana ^a   Spaggiari, Lorenzo ^a  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

Fluorodeoxyglucose; Lung cancer; Lymph node involvement; Positron emission tomography; SUV; Tumor size

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADENOSQUAMOUS CARCINOMA; ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER PATIENT; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DRUG UPTAKE; FEMALE; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; HUMAN TISSUE; LARGE CELL CARCINOMA; LUNG ADENOCARCINOMA; LUNG LOBECTOMY; LUNG NODULE; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LUNG SQUAMOUS CELL CARCINOMA; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE COMPLICATION; PREDICTION; PRIORITY JOURNAL; RADICAL RESECTION; RETROSPECTIVE STUDY; SURGICAL MORTALITY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; EARLY DETECTION OF CANCER; FEMALE; FLUORODEOXYGLUCOSE F18; GLUCOSE; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 79952533704     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2010.11.059     Document Type: Article

References (25)

1. Pastorino U., Landoni C., Marchianò A., Calabrò E., Sozzi G., Miceli R., Picchio M., Mariani L., Messa C., Fazio F. Fluorodeoxyglucose uptake measured by positron emission tomography and standardized uptake value predicts long-term survival of CT screening detected lung cancer in heavy smokers. J Thorac Oncol 2009, 4:1352-1356.
2. Detterbeck Fc, Boffa D.J., Tanoue L.T. The new lung cancer staging system. Chest 2009, 136:260-271.
3. Harpole D.H., Herndon J.H., Young W.G. Stage I non-small cell lung cancer: a multivariate analysis of treatment methods and patterns of recurrence. Cancer 1995, 76:787-796.
4. Allen M.S., Darling G.E., Pechet T.T.V., Mitchell J., Herndon J.E., Landreneau R.J., Inculet R.I., Jones D.R., Meyers B.F., Harpole D.H., Putnam J.B., Rusch V.W. Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer: initial results of the randomized, prospective ACOSOG Z0030 trials. Ann Thorac Surg 2006, 81:1013-1019. the ACOSOG Z0030 Study Group.
5. Behzadi A., Ung Y., Lowe V., Deschamps C. The role of positron emission tomography in the management of non-small cell lung cancer. Can J Surg 2009, 52:235-242.
6. Ginsberg R.J., Rubistein L.V. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg 1995, 60:615.
7. Groome P.A., Bolejack G., Crowley J.J., Kennedy C., Krasnik M., Sobin L.H., Goldstraw P. The IASLC Lung Cancer Staging Project: validation of the proposals for revision of the T, N, and M descriptors and consequent stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol 2007, 2:694.
8. Martini N., Bains M.S., Burt M.E., Zakowski M.F., McCormack P., Rusch V.W., Ginsberg R.J. Incidence of local recurrence and second primary tumors in resected stage I lung cancer. J Thorac Cardiovasc Surg 1995, 109:120-129.
9. Gajra A., Newman N., Gamble G.P., Abraham N.Z., Kohman L.J., Graziano S.L. Impact of tumor size on survival in stage IA non-small cell lung cancer: a case for subdividing stage IA disease. Lung Cancer 2003, 42:51.
10. Naruke T., Goya T., Tsuchiya R., Suemasu K. Prognosis and survival in resected lung cancer based on the new international staging system. J Thorac Cardiovasc Surg 1988, 96:440-447.
11. Asamura H., Nakayama H., Kondo H. Lymph node involvement, recurrence, and prognosis in resected small, peripheral, non-small-cell lung carcinoma: are these carcinoma candidates for video-assisted lobectomy?. J Thorac Cardiovasc Surg 1996, 111:1125-1134.
12. Suzuki K., Nagai K., Yoshida J. Prognostic factors in clinical stage I non-small cell lung cancer. Ann Thorac Surg 1999, 67:927-932.
13. Sugi K., Nawata K., Fujita N., Ueda K., Tanaka T., Matsuoka T., Kaneda Y., Esato K. Systematic lymph node dissection for clinically diagnosed peripheral non-small-cell lung cancer less than 2cm in diameter. World J Surg 1998, 22:290-294.
14. Flieder B.D., Port J.L., Korst R.J., Christos P.J., Levin M.A., Becker D.E., Altorki N.K. Tumor size is a determinant of stage distribution in T1 non-small cell lung cancer. Chest 2005, 128:2304-2308.
15. Ishida T., Yano T., Maeda K., Kaneko S., Tateishi M., Sugimachi K. Strategy for lymphadenectomy in lung cancer three centimeters or less in diameter. Ann Thorac Surg 1990, 50:708-713.
16. Konaka C., Ikeda N., Hiyoshi T., Tsuji K., Hirano T., Kawate N., Ebihara Y., Kato H. Peripheral non-small cell lung cancers 2.0cm or less in 290 diameter: proposed criteria for limited pulmonary resection based upon clinico-pathological presentation. Lung Cancer 1998, 21:185-191.
17. Bryant A.S., Cerfolio R.J. The maximum standardized uptake values on integrated FDG-PET/CT is useful in differentiating benign from malignant pulmonary nodules. Ann Thorac Surg 2006, 82:1016-1020.
18. Divisi D., Di Tommaso S., Di Leonardo G., Brianzoni E., De Vico A., Crisci R. 18-Fluorine fluorodeoxyglucose positron emission tomography with computerized tomography versus computerized tomography alone for the management of solitary lung nodules with diameters inferior to 1.5cm. Thorac Cardiovasc Surg 2010, 58:422-426.
19. Higashi K., Ueda Y., Yagishita M., Arisaka Y., Sakurai A., Seki H., Nambu Y., Oguchi M., Shikata H., Taki S., Tonami H., Katsuda S., Yamamoto I. FDG PET measurement of the proliferative potential of non-small cell lung cancer. J Nucl Med 2000, 41:85-92.
20. Yoshioka M., Ichiguchi O. Selection of sublobar resection for c-Stage IA non-small cell lung cancer based on a combination of structural imaging by CT and functional imaging by FDG PET. Ann Thorac Cardiovasc Surg 2009, 15(2):82-88.
21. Zhoua Q., Suzuki K., Anami Y., Oh S., Takamochi K. Clinicopathologic features in resected subcentimeter lung cancer - status of lymph node metastases. Interact Cardiovasc Thorac Surg 2010, 10:53-57.
22. Ludwig M.S., Goodman M., Miller D.L., Johnstone P.A. Postoperative survival and the number of lymph nodes sampled during resection of node-negative non-small cell lung cancer. Chest 2005, 128:1545-1550.
23. Lardinois D., Suter H., Hakki H., Rousson V., Betticher D., Rus H.B. Morbidity, survival, and site of recurrence after mediastinal lymph-node dissection versus systematic sampling after complete resection for non-small cell lung cancer. Ann Thorac Surg 2005, 80:268-275.
24. Izbicki J.R., Passlick B., Karg O., Bloechle C., Pantel K., Knoefel W.T., Thetter O. Impact of radical systematic mediastinal lymphadenectomy on tumor staging in lung cancer. Ann Thorac Surg 1995, 59:209-214.
25. Doddoli C., Aragon A., Barlesi F., Chetaille B., Robitail S., Giudicelli R., Fuentes P., Thomas P. Does the extent of lymph node dissection influence outcome in patients with stage I non-small-cell lung cancer?. Eur J Cardiothorac Surg 2005, 27:680-685.